InvestorsHub Logo
Followers 20
Posts 1930
Boards Moderated 0
Alias Born 03/21/2010

Re: rafunrafun post# 348550

Friday, 07/30/2021 11:29:18 AM

Friday, July 30, 2021 11:29:18 AM

Post# of 425967
Has anybody asked or answered the question if the infringement beyond the Marine indication is cumulative? That is, if it is somehow proven that the Marine indication represents 10% of Vascepa's total market, and the generics combined are taking, say, 18%, is the generic (e.g., Hikma) that's taking 12% going to be the infringer, but not Reddy who is only taking 6%? Or do they both get dinged just because?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News